UNITED THERAPEUTICS CORP (UTHR) Fundamental Analysis & Valuation

NASDAQ:UTHR • US91307C1027

Current stock price

584.56 USD
+18.86 (+3.33%)
Last:

This UTHR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

9

1. UTHR Profitability Analysis

1.1 Basic Checks

  • UTHR had positive earnings in the past year.
  • UTHR had a positive operating cash flow in the past year.
  • In the past 5 years UTHR has always been profitable.
  • UTHR had a positive operating cash flow in each of the past 5 years.
UTHR Yearly Net Income VS EBIT VS OCF VS FCFUTHR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B

1.2 Ratios

  • The Return On Assets of UTHR (16.94%) is better than 95.74% of its industry peers.
  • Looking at the Return On Equity, with a value of 18.81%, UTHR belongs to the top of the industry, outperforming 94.97% of the companies in the same industry.
  • With an excellent Return On Invested Capital value of 16.10%, UTHR belongs to the best of the industry, outperforming 96.13% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for UTHR is significantly below the industry average of 27.63%.
  • The 3 year average ROIC (15.88%) for UTHR is below the current ROIC(16.10%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 16.94%
ROE 18.81%
ROIC 16.1%
ROA(3y)15.64%
ROA(5y)13.63%
ROE(3y)17.94%
ROE(5y)16.2%
ROIC(3y)15.88%
ROIC(5y)14.43%
UTHR Yearly ROA, ROE, ROICUTHR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40

1.3 Margins

  • With an excellent Profit Margin value of 41.94%, UTHR belongs to the best of the industry, outperforming 97.29% of the companies in the same industry.
  • In the last couple of years the Profit Margin of UTHR has grown nicely.
  • UTHR has a better Operating Margin (47.63%) than 99.42% of its industry peers.
  • UTHR's Operating Margin has improved in the last couple of years.
  • UTHR has a better Gross Margin (87.92%) than 89.36% of its industry peers.
  • UTHR's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 47.63%
PM (TTM) 41.94%
GM 87.92%
OM growth 3Y-2.34%
OM growth 5Y3.56%
PM growth 3Y3.74%
PM growth 5Y3.86%
GM growth 3Y-1.56%
GM growth 5Y-1.06%
UTHR Yearly Profit, Operating, Gross MarginsUTHR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. UTHR Health Analysis

2.1 Basic Checks

  • UTHR has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • Compared to 1 year ago, UTHR has less shares outstanding
  • UTHR has less shares outstanding than it did 5 years ago.
  • There is no outstanding debt for UTHR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
UTHR Yearly Shares OutstandingUTHR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
UTHR Yearly Total Debt VS Total AssetsUTHR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

  • An Altman-Z score of 22.02 indicates that UTHR is not in any danger for bankruptcy at the moment.
  • With an excellent Altman-Z score value of 22.02, UTHR belongs to the best of the industry, outperforming 88.97% of the companies in the same industry.
  • There is no outstanding debt for UTHR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 22.02
ROIC/WACC1.75
WACC9.22%
UTHR Yearly LT Debt VS Equity VS FCFUTHR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B

2.3 Liquidity

  • A Current Ratio of 6.60 indicates that UTHR has no problem at all paying its short term obligations.
  • UTHR has a better Current ratio (6.60) than 64.99% of its industry peers.
  • A Quick Ratio of 6.28 indicates that UTHR has no problem at all paying its short term obligations.
  • UTHR has a better Quick ratio (6.28) than 64.22% of its industry peers.
Industry RankSector Rank
Current Ratio 6.6
Quick Ratio 6.28
UTHR Yearly Current Assets VS Current LiabilitesUTHR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. UTHR Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 13.41% over the past year.
  • UTHR shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 19.23% yearly.
  • The Revenue has grown by 10.61% in the past year. This is quite good.
  • The Revenue has been growing by 16.50% on average over the past years. This is quite good.
EPS 1Y (TTM)13.41%
EPS 3Y22.93%
EPS 5Y19.23%
EPS Q2Q%24.39%
Revenue 1Y (TTM)10.61%
Revenue growth 3Y18.02%
Revenue growth 5Y16.5%
Sales Q2Q%7.38%

3.2 Future

  • The Earnings Per Share is expected to grow by 10.97% on average over the next years. This is quite good.
  • Based on estimates for the next years, UTHR will show a quite strong growth in Revenue. The Revenue will grow by 11.61% on average per year.
EPS Next Y7.05%
EPS Next 2Y9.44%
EPS Next 3Y9.73%
EPS Next 5Y10.97%
Revenue Next Year4.35%
Revenue Next 2Y9.22%
Revenue Next 3Y11.18%
Revenue Next 5Y11.61%

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
UTHR Yearly Revenue VS EstimatesUTHR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B
UTHR Yearly EPS VS EstimatesUTHR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10 20 30 40 50

More info and screens

Find the best growth stocksShow best growing peers

6

4. UTHR Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 20.95 indicates a rather expensive valuation of UTHR.
  • Based on the Price/Earnings ratio, UTHR is valued cheaper than 93.23% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of UTHR to the average of the S&P500 Index (26.21), we can say UTHR is valued slightly cheaper.
  • With a Price/Forward Earnings ratio of 19.57, UTHR is valued on the expensive side.
  • 94.58% of the companies in the same industry are more expensive than UTHR, based on the Price/Forward Earnings ratio.
  • The average S&P500 Price/Forward Earnings ratio is at 23.10. UTHR is around the same levels.
Industry RankSector Rank
PE 20.95
Fwd PE 19.57
UTHR Price Earnings VS Forward Price EarningsUTHR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, UTHR is valued cheaply inside the industry as 95.16% of the companies are valued more expensively.
  • 94.58% of the companies in the same industry are more expensive than UTHR, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 24.75
EV/EBITDA 12.81
UTHR Per share dataUTHR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • The excellent profitability rating of UTHR may justify a higher PE ratio.
PEG (NY)2.97
PEG (5Y)1.09
EPS Next 2Y9.44%
EPS Next 3Y9.73%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. UTHR Dividend Analysis

5.1 Amount

  • No dividends for UTHR!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

UTHR Fundamentals: All Metrics, Ratios and Statistics

UNITED THERAPEUTICS CORP

NASDAQ:UTHR (4/8/2026, 12:46:56 PM)

584.56

+18.86 (+3.33%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-25
Earnings (Next)04-28
Inst Owners98.05%
Inst Owner Change0%
Ins Owners1.81%
Ins Owner Change32.81%
Market Cap25.62B
Revenue(TTM)3.18B
Net Income(TTM)1.33B
Analysts81.9
Price Target603.09 (3.17%)
Short Float %6.63%
Short Ratio5.85
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.35%
Min EPS beat(2)-2.35%
Max EPS beat(2)5.05%
EPS beat(4)1
Avg EPS beat(4)-1.8%
Min EPS beat(4)-9.46%
Max EPS beat(4)5.05%
EPS beat(8)2
Avg EPS beat(8)-2.1%
EPS beat(12)6
Avg EPS beat(12)0.77%
EPS beat(16)8
Avg EPS beat(16)-0.29%
Revenue beat(2)0
Avg Revenue beat(2)-4.27%
Min Revenue beat(2)-4.72%
Max Revenue beat(2)-3.81%
Revenue beat(4)1
Avg Revenue beat(4)-1.12%
Min Revenue beat(4)-4.72%
Max Revenue beat(4)6.71%
Revenue beat(8)4
Avg Revenue beat(8)0.39%
Revenue beat(12)7
Avg Revenue beat(12)1.48%
Revenue beat(16)9
Avg Revenue beat(16)1.26%
PT rev (1m)10.29%
PT rev (3m)15.94%
EPS NQ rev (1m)-2.19%
EPS NQ rev (3m)-5.22%
EPS NY rev (1m)0%
EPS NY rev (3m)0.38%
Revenue NQ rev (1m)0.58%
Revenue NQ rev (3m)-1.08%
Revenue NY rev (1m)-0.64%
Revenue NY rev (3m)-1.47%
Valuation
Industry RankSector Rank
PE 20.95
Fwd PE 19.57
P/S 8.05
P/FCF 24.75
P/OCF 16.41
P/B 3.61
P/tB 3.67
EV/EBITDA 12.81
EPS(TTM)27.9
EY4.77%
EPS(NY)29.87
Fwd EY5.11%
FCF(TTM)23.62
FCFY4.04%
OCF(TTM)35.62
OCFY6.09%
SpS72.61
BVpS161.9
TBVpS159.25
PEG (NY)2.97
PEG (5Y)1.09
Graham Number318.8
Profitability
Industry RankSector Rank
ROA 16.94%
ROE 18.81%
ROCE 20.71%
ROIC 16.1%
ROICexc 26.8%
ROICexgc 27.52%
OM 47.63%
PM (TTM) 41.94%
GM 87.92%
FCFM 32.53%
ROA(3y)15.64%
ROA(5y)13.63%
ROE(3y)17.94%
ROE(5y)16.2%
ROIC(3y)15.88%
ROIC(5y)14.43%
ROICexc(3y)29.26%
ROICexc(5y)26.59%
ROICexgc(3y)30.21%
ROICexgc(5y)27.3%
ROCE(3y)20.42%
ROCE(5y)18.56%
ROICexgc growth 3Y0.25%
ROICexgc growth 5Y6.53%
ROICexc growth 3Y-0.12%
ROICexc growth 5Y7.38%
OM growth 3Y-2.34%
OM growth 5Y3.56%
PM growth 3Y3.74%
PM growth 5Y3.86%
GM growth 3Y-1.56%
GM growth 5Y-1.06%
F-Score8
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 614.49%
Cap/Sales 16.53%
Interest Coverage 112.28
Cash Conversion 97.49%
Profit Quality 77.56%
Current Ratio 6.6
Quick Ratio 6.28
Altman-Z 22.02
F-Score8
WACC9.22%
ROIC/WACC1.75
Cap/Depr(3y)462.52%
Cap/Depr(5y)380.04%
Cap/Sales(3y)11.66%
Cap/Sales(5y)9.87%
Profit Quality(3y)81.3%
Profit Quality(5y)87.1%
High Growth Momentum
Growth
EPS 1Y (TTM)13.41%
EPS 3Y22.93%
EPS 5Y19.23%
EPS Q2Q%24.39%
EPS Next Y7.05%
EPS Next 2Y9.44%
EPS Next 3Y9.73%
EPS Next 5Y10.97%
Revenue 1Y (TTM)10.61%
Revenue growth 3Y18.02%
Revenue growth 5Y16.5%
Sales Q2Q%7.38%
Revenue Next Year4.35%
Revenue Next 2Y9.22%
Revenue Next 3Y11.18%
Revenue Next 5Y11.61%
EBIT growth 1Y4.68%
EBIT growth 3Y15.26%
EBIT growth 5Y20.65%
EBIT Next Year11.69%
EBIT Next 3Y9.49%
EBIT Next 5Y-7.27%
FCF growth 1Y-4.2%
FCF growth 3Y15.97%
FCF growth 5Y8.25%
OCF growth 1Y17.64%
OCF growth 3Y24.84%
OCF growth 5Y15.62%

UNITED THERAPEUTICS CORP / UTHR Fundamental Analysis FAQ

What is the fundamental rating for UTHR stock?

ChartMill assigns a fundamental rating of 7 / 10 to UTHR.


What is the valuation status of UNITED THERAPEUTICS CORP (UTHR) stock?

ChartMill assigns a valuation rating of 6 / 10 to UNITED THERAPEUTICS CORP (UTHR). This can be considered as Fairly Valued.


How profitable is UNITED THERAPEUTICS CORP (UTHR) stock?

UNITED THERAPEUTICS CORP (UTHR) has a profitability rating of 9 / 10.


Can you provide the PE and PB ratios for UTHR stock?

The Price/Earnings (PE) ratio for UNITED THERAPEUTICS CORP (UTHR) is 20.95 and the Price/Book (PB) ratio is 3.61.